Phase I Study of Alpha-Melanocyte Stimulating Hormone in Patients With Acute Renal Failure - Related Studies

Phase I Study of Alpha-Melanocyte Stimulating Hormone in Patients With Acute Renal Failure

This study is currently recruiting participants.

Study NCT00004496. Last updated on June 23, 2005. Information provided by FDA Office of Orphan Products Development

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Acute Renal Failure

2	Additional conditions recognized in this trial
		Kidney Failure
		Kidney Failure, Acute

3	More general conditions related to this trial
		Kidney Diseases
		Renal Insufficiency
		Renal Insufficiency, Acute
		Urologic Diseases

4	Additional drug interventions recognized in this trial
		Alpha-MSH
		Melanocyte-Stimulating Hormones

5	More general drug interventions related to this trial
		Hormones
		Hormones, Hormone Substitutes, and Hormone Antagonists
		Pharmacologic Actions
		Physiological Effects of Drugs

6	Sponsors listed in this trial
		FDA Office of Orphan Products Development
		University of Texas